Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 41 Records) |
| Query Trace: Neoplasms and meta-analysis and PIK3CA[original query] |
|---|
| Predictive value of K-ras and PIK3CA in non-small cell lung cancer patients treated with EGFR-TKIs: a systemic review and meta-analysis. Cancer biology & medicine 2015 Jun 12 (2): 126-39. Chen Jie-Ying, Cheng Ya-Nan, Han Lei, Wei Feng, Yu Wen-Wen, Zhang Xin-Wei, Cao Shui, Yu Jin- |
| The predictive and prognostic role of phosphatase phosphoinositol-3 (PI3) kinase (PIK3CA) mutation in HER2-positive breast cancer receiving HER2-targeted therapy: a meta-analysis. Breast cancer research and treatment 2015 Aug 152 (3): 463-76. Ibrahim Ezzeldin M, Kazkaz Ghieth A, Al-Mansour Mubarak M, Al-Foheidi Meteb |
| PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies. Clinical oncology (Royal College of Radiologists (Great Britain)) 2015 Dec . Paleari L, Puntoni M, Clavarezza M, DeCensi M, Cuzick J, DeCensi |
| Assessing the potential value of long interspersed element-1 hypomethylation in colorectal cancer: evidence from retrospective studies. OncoTargets and therapy 0 8 3265-3276. Tang Jie-Ting, Wang Zhen-Hua, Fang Jing-Yu |
| Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy. World journal of gastroenterology 2016 Aug 22 (30): 6944-54. Lo Nigro Cristiana, Ricci Vincenzo, Vivenza Daniela, Granetto Cristina, Fabozzi Teresa, Miraglio Emanuela, Merlano Marco |
| Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2016 Jul . Mei Z, Duan C, Li C, Cui L, Ogino |
| Diagnostic Accuracy of PIK3CA Mutation Detection by Circulating Free DNA in Breast Cancer: A Meta-Analysis of Diagnostic Test Accuracy. PloS one 2016 11 (6): e0158143. Zhou Yidong, Wang Changjun, Zhu Hanjiang, Lin Yan, Pan Bo, Zhang Xiaohui, Huang Xin, Xu Qianqian, Xu Yali, Sun Qia |
| Clinical, Pathological, and Molecular Characteristics of CpG Island Methylator Phenotype in Colorectal Cancer: A Systematic Review and Meta-analysis. Translational oncology 2018 8 11 (5): 1188-1201. Advani Shailesh M, Advani Pragati, DeSantis Stacia M, Brown Derek, VonVille Helena M, Lam Michael, Loree Jonathan M, Mehrvarz Sarshekeh Amir, Bressler Jan, Lopez David S, Daniel Carrie R, Swartz Michael D, Kopetz Sco |
| PIK3CA mutations and their response to neoadjuvant treatment in early breast cancer: A systematic review and meta-analysis. Thoracic cancer 2018 Mar . Fan Hongwei, Li Chao, Xiang Qian, Xu Ling, Zhang Zhuo, Liu Qianxin, Zhang Tonttong, Zhou Ying, Zhao Xia, Cui Yim |
| Association between PIK3CA alteration and prognosis of gastric cancer patients: a meta-analysis. Oncotarget 2018 2 9 (7): 7651-7659. Li Hua, Chen Shubo, Li Hui, Cui Jianxin, Gao Yunhe, Wu Dianchao, Luan Shangfeng, Qin Yan, Zhai Tongshan, Liu Dengxiang, Huo Zhib |
| Association between PD-L1 expression and driver gene status in non-small-cell lung cancer: a meta-analysis. Oncotarget 2018 Jan 9 (7): 7684-7699. Lan Bo, Ma Chengxi, Zhang Chengyan, Chai Shoujie, Wang Pingli, Ding Liren, Wang K |
| Liquid biopsy prediction of axillary lymph node metastasis, cancer recurrence, and patient survival in breast cancer: A meta-analysis. Medicine 2018 Oct 97 (42): e12862. Lee Ju-Han, Jeong Hoiseon, Choi Jung-Woo, Oh Hwa Eun, Kim Young-S |
| Mutations of key driver genes in colorectal cancer progression and metastasis. Cancer metastasis reviews 2018 Jan . Huang Dongdong, Sun Wenjie, Zhou Yuwei, Li Peiwei, Chen Fang, Chen Hanwen, Xia Dajing, Xu Enping, Lai Maode, Wu Yihua, Zhang Hong |
| PIK3CA mutation and clinicopathological features of colorectal cancer: a systematic review and Meta-Analysis. Acta oncologica (Stockholm, Sweden) 2019 9 59 (1): 66-74. Jin Juan, Shi Yaqin, Zhang Shu, Yang Shuof |
| Prognostic impact of PIK3CA protein expression in triple negative breast cancer and its subtypes. Journal of cancer research and clinical oncology 2019 Jul . Elfgen C, Reeve K, Moskovszky L, Güth U, Bjelic-Radisic V, Fleisch M, Tausch C, Varga |
| Associations of PIK3CA mutations with clinical features and prognosis in gastric cancer. Future oncology (London, England) 2019 Mar . Shen Xiaobing, Zhao Ying, Chen Xiaowei, Sun Haixiang, Liu Mengqi, Zhang Wenwen, Jiang Fei, Li Pengf |
| Clinical Significance of PIK3CA Gene in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. BioMed research international 2020 9 2020 3608241. Wang Yi, Wang Yan, Li Jialong, Li Jue, Che Guow |
| PIK3CA Mutations and Their Impact on Survival Outcomes of Patients with Cervical Cancer: A Systematic Review. Acta cytologica 2020 Jul 1-9. Pergialiotis Vasilios, Nikolaou Christina, Haidopoulos Dimitrios, Frountzas Maximos, Thomakos Nikolaos, Bellos Ioannis, Papapanagiotou Angeliki, Rodolakis Alexandr |
| The Predictive Role of PIK3CA Mutation Status on PI3K Inhibitors in HR+ Breast Cancer Therapy: A Systematic Review and Meta-Analysis. BioMed research international 2020 5 2020 1598037. Wang Mingming, Li Jin, Huang Jiangsheng, Luo M |
| Signal transduction pathway mutations in gastrointestinal (GI) cancers: a systematic review and meta-analysis. Scientific reports 2020 10 10 (1): 18713. Tabibzadeh Alireza, Tameshkel Fahimeh Safarnezhad, Moradi Yousef, Soltani Saber, Moradi-Lakeh Maziar, Ashrafi G Hossein, Motamed Nima, Zamani Farhad, Motevalian Seyed Abbas, Panahi Mahshid, Esghaei Maryam, Ajdarkosh Hossein, Mousavi-Jarrahi Alireza, Niya Mohammad Hadi Karbala |
| Driver and novel genes correlated with metastasis of non-small cell lung cancer: A comprehensive analysis. Pathology, research and practice 2021 Jul 224 153551. Wu Yongfeng, Ni Heng, Yang Dexin, Niu Yuequn, Chen Kelie, Xu Jinming, Wang Fang, Tang Song, Shi Yu, Zhang Honghe, Hu Jian, Xia Dajing, Wu Yih |
| Mutations of key driver genes in gastric cancer metastasis risk: a systematic review and meta-analysis. Expert review of molecular diagnostics 2021 7 21 (9): 963-972. Wang Jin, Shao Xinye, Liu Yang, Shi Ruichuan, Yang Bowen, Xiao Jiawen, Liu Yunpeng, Qu Xiujuan, Li Z |
| Worldwide prevalence of PI3K-AKT-mTOR pathway mutations in head and neck cancer: A systematic review and meta-analysis. Critical reviews in oncology/hematology 2021 Mar 160 103284. Moura Adriana Castelo de, Assad Daniele Xavier, Amorim Dos Santos Juliana, Porto de Toledo Isabela, Barra Gustavo Barcelos, Castilho Rogerio Moraes, Squarize Cristiane Helena, Guerra Eliete Neves Sil |
| Systematic Review and Meta-analysis of the Most Common Genetic Mutations in Esophageal Squamous Cell Carcinoma. Journal of gastrointestinal cancer 2021 Oct . Naseri Amirreza, Salehi-Pourmehr Hanieh, Majidazar Reza, Seraji Parya, Rezazadeh-Gavgani Erfan, Zehtabi Mojtaba, Kiani-Kezbin Hamed, Salehnia Fatemeh, Hassannezhad Sina, Hajikamanj Arash, Raeisi Morta |
| PIK3CA mutation status, progression and survival in advanced HR?+?/HER2- breast cancer: a meta-analysis of published clinical trials. BMC cancer 2022 Sep 22 (1): 1002. Fillbrunn Mirko, Signorovitch James, André Fabrice, Wang Iris, Lorenzo Ines, Ridolfi Antonia, Park Jinhee, Dua Akanksha, Rugo Hope |
| Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer. Targeted oncology 2022 Jun . Tan Elaine S, Fan Wenyi, Knepper Todd C, Schell Michael J, Sahin Ibrahim H, Fleming Jason B, Xie H |
| Predictive and prognostic value of PIK3CA mutations in HER2-positive breast cancer treated with tyrosine kinase inhibitors: A systematic review and meta-analysis. Biochimica et biophysica acta. Reviews on cancer 2022 12 1878 (1): 188847. Shi Qiyun, Xuhong Juncheng, Tian Hao, Qu Man, Zhang Yi, Jiang Jun, Qi Xiaow |
| Association of PIK3CA mutation with outcomes in HER2-positive breast cancer treated with anti-HER2 therapy: A meta-analysis and bioinformatic analysis of TCGA?BRCA data. Translational oncology 2023 8 37 101738. Haizhu Chen, Xingbin Hu, Daquan Wang, Ying Wang, Yunfang Yu, Herui Y |
| PIK3CA mutations and their impact on survival outcomes of patients with endometrial cancer: A systematic review and meta-analysis. PloS one 2023 3 18 (3): e0283203. Bredin Hanna K, Krakstad Camilla, Hoivik Erling |
| Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis. BMC cancer 2023 11 23 (1): 1117. Xiaona Lu, Yuyao Li, Yue Li, Xuemei Zhang, Jia Shi, Hai Feng, Zhuo Yu, Yueqiu G |
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 28, 2023
- Content source: